Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Rare ginsenoside compound containing rare ginsenoside Rk1

A technology of ginsenoside and composition, applied in the field of biomedicine

Inactive Publication Date: 2017-02-22
SHAANXI GIANT BIOTECHNOLOGY CO LTD
View PDF7 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0003] However, there is no report on how to combine ginsenosides on the basis of single components to enhance their antitumor effects and prepare highly efficient and low-toxic antitumor drugs.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Rare ginsenoside compound containing rare ginsenoside Rk1
  • Rare ginsenoside compound containing rare ginsenoside Rk1
  • Rare ginsenoside compound containing rare ginsenoside Rk1

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0049] Example 1 Preparation of Ginsenoside Rk1 Capsules

[0050] Weigh 10kg of ginsenoside Rk1, 0.2kg of citric acid, add 68.5kg of starch, mix well, sieve, use ethanol aqueous solution as binder to make a suitable soft material, granulate with 18 mesh sieve, and dry in an oven at 60°C for 5 hours. Sieve with a 16-mesh sieve, add 500g of magnesium stearate, and mix well to obtain capsules.

Embodiment 2

[0051] Example 2 Ginsenoside Rk1 Tablet Preparation

[0052] Take ginsenoside Rk1 50kg, citric acid 1kg, pulverize into fine powder, add microcrystalline cellulose 10kg, sodium carboxymethyl starch 2kg, mix well, wet granulate, dry, add talcum powder 2kg, magnesium stearate 0.3kg, Tablets were made by conventional tablet preparation process.

Embodiment 3

[0053] Example 3 Preparation of Ginsenoside Rk1 Powder

[0054] Take 40kg of ginsenoside Rk1 and 0.8kg of citric acid, grind them into fine powder, add 0.3kg of magnesium stearate, mix evenly, and pack into powders.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
Half inhibitory concentrationaaaaaaaaaa
Login to View More

Abstract

The invention provides a rare ginsenoside compound containing rare ginsenoside Rk1. The rare ginsenoside compound contains ginsenoside Rk1 and edible C2-C6 organic dicarboxylic or tricarboxylic acid. Relative to 100 parts by weight of ginsenoside Rk1, the compound contains 0.5-5 parts by weight of edible C2-C6 organic dicarboxylic or tricarboxylic acid. The rare ginsenoside compound has remarkable anti-tumor activity and is efficient and low in toxicity.

Description

technical field [0001] The invention relates to the field of biomedicine, in particular to a rare ginsenoside composition containing rare ginsenoside Rk1, which has anti-tumor activity, high efficiency and low toxicity. Background technique [0002] Cancer is the second most threatening human disease after cerebrovascular disease. The incidence of cancer in my country exceeds 3 million people every year, and the incidence of lung cancer, breast cancer, and esophageal cancer increases year by year, among which the annual growth rate of lung cancer incidence is 26.8%, and the annual growth rate of breast cancer incidence is 6.8%. Over the past 30 years, the mortality rate of breast cancer has increased by 96%, and the mortality rate of lung cancer has soared by 465%. my country's cancer prevention and control work is urgent and the situation is grim. [0003] However, there has not been any report on how to combine ginsenosides on the basis of single components to enhance the...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61K31/704A61K47/12A61P35/00
CPCA61K31/704A61K47/12
Inventor 段志广范代娣马晓轩黄蓉范翠英张婧婧严建亚
Owner SHAANXI GIANT BIOTECHNOLOGY CO LTD
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products